# Evaluation of the Effect of Gabexate Mesilate in the Hepatocyte Protection After Liver Resection

> **NCT02710266** · PHASE3 · TERMINATED · sponsor: **Yonsei University** · enrollment: 2 (actual)

## Conditions studied

- Liver Disease

## Interventions

- **DRUG:** Preoperative Gabexate Mesilate group
- **DRUG:** Intraoperative Gabexate Mesilate group
- **DRUG:** hepatectomy with dextrose water

## Key facts

- **NCT ID:** NCT02710266
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-02-24
- **Primary completion:** 2017-02-25
- **Final completion:** 2017-02-25
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** This study was closed earlier than planned because targeted participant recruitment is not smooth.
- **Last updated:** 2018-07-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02710266

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02710266, "Evaluation of the Effect of Gabexate Mesilate in the Hepatocyte Protection After Liver Resection". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02710266. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*